SecBot SecBot
SC 13G ·Filed Nov 6, 2026

WGS

GeneDx Holdings Corp.
NEUTRAL
Impact 3/10
Horizonimmediate Processed10d 13h ago SEC0001644956-26-000030
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments that could indicate a shift from passive to active intent, though the current filing explicitly disclaims control-related purpose.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$62.37
T+0 close · Nov 6, 2026 · via day close
Latest settled
−16.03%
T+5 · $52.37
Vs SPY
−18.63%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $62.37entry
  2. T+1 · 8d ago +5.37%α +3.00% · $65.72
  3. T+5 · 4d ago −16.03%α −18.63% · $52.37
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

William Blair Investment Management disclosed a 5.2% passive stake in GeneDx Holdings Corp. via a new Schedule 13G filing, holding 1,560,247 shares as of September 30, 2026. The filing certifies passive intent with no control-related purpose.

Key Financial Metrics

Stake
5.2%
Investor
William Blair Investment Management, LLC
Investor Type
mutual fund

Key Facts

  • William Blair Investment Management filed a new Schedule 13G disclosing beneficial ownership of 1,560,247 shares of GeneDx Holdings Corp. common stock.
  • The stake represents 5.2% of shares outstanding as of September 30, 2026.
  • The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • William Blair Investment Management is an investment adviser (IA) based in Chicago, IL.

Financial Impact

5.2% stake valued at approximately $109M based on $2.1B market cap

ownership concentration

Risk Factors

  • No material risks identified from this passive stake disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001644956-26-000030
Document: 0001644956-26-000030-index.html0001644956-26-000030
Document: 0001644956-26-000030.txt0001644956-26-000030

Track record

13 reports on WGS

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 Now $51.02 −2.58% settles Feb 11
  2. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 Now $51.02 −6.95% settles Feb 8
  3. Nov 6, 202610d ago SC 13G Neutral 3/10 Viewing Entry $62.37 Now $51.02 −18.20% settles Feb 4
  4. Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 Now $51.02 +47.85% settles Dec 15
  5. Sep 11, 20269w ago Insider Cluster Neutral 2/10 Entry $89.74 Now $51.02 −43.15% settles Dec 8
  6. Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 Now $51.02 −41.17% settles Nov 27
  7. Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 Now $51.02 −15.81% ▲ +38.55% +37.55% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Entry $59.92 to $85.87 Now $51.02 −14.85% ▲ +43.31% +40.04% vs SPY
  9. Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 Now $51.02 −9.43% ▲ +53.95% +50.14% vs SPY
  10. May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 Now $51.02 +7.80% ▲ +63.51% +59.21% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026